Nuveen Asset Management Portfolio holdings
Nuveen Asset Management, founded in 1898 by John Nuveen and headquartered in Chicago, Illinois, is a leading global investment manager and subsidiary of TIAA, overseeing hundreds of billions in assets with a focus on fixed income, equities, and sustainable investing. Initially known for municipal bonds, Nuveen has expanded into a broad range of strategies, including mutual funds, ETFs, closed-end funds, and private capital solutions, serving institutional investors, financial advisors, and individuals. The firm emphasizes income-generating investments and ESG (environmental, social, governance) integration, leveraging its deep research capabilities and a century-long legacy in the bond market. With a strong presence in North America and growing international reach, Nuveen blends tradition with innovation to meet diverse client needs in the evolving investment landscape.
Top Buys
| 1 |
Intel
INTC
|
+$661M |
| 2 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$484M |
| 3 |
Amazon
AMZN
|
+$482M |
| 4 |
Netflix
NFLX
|
+$345M |
| 5 |
Pfizer
PFE
|
+$314M |
Top Sells
| 1 |
Apple
AAPL
|
+$900M |
| 2 |
Microsoft
MSFT
|
+$393M |
| 3 |
UnitedHealth
UNH
|
+$388M |
| 4 |
Merck
MRK
|
+$272M |
| 5 |
Bank of America
BAC
|
+$265M |
Sector Composition
| 1 | Technology | 22.26% |
| 2 | Healthcare | 14.77% |
| 3 | Financials | 12.79% |
| 4 | Consumer Discretionary | 10.52% |
| 5 | Communication Services | 9.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1901
Trinity Industries
TRN
$2.28B
| $3.52M | ﹤0.01% |
219,012
+2,714
| +1% | +$43.6K |
|
|
CDR
1902
DELISTED
Cedar Realty Trust, Inc
CDR
| $3.49M | ﹤0.01% |
105,793
-46,384
| -30% | -$1.53M |
|
1903
Gates Industrial
GTES
$6.68B
| $3.48M | ﹤0.01% |
471,789
+303,791
| +181% | +$2.24M |
|
|
PGNX
1904
DELISTED
Progenics Pharmaceuticals Inc
PGNX
| $3.48M | ﹤0.01% |
915,934
+266,409
| +41% | +$1.01M |
|
1905
Avis
CAR
$5.47B
| $3.48M | ﹤0.01% |
250,122
+28,430
| +13% | +$395K |
|
1906
LeMaitre Vascular
LMAT
$2.11B
| $3.46M | ﹤0.01% |
138,971
+24,679
| +22% | +$615K |
|
1907
Mesa Laboratories
MLAB
$330M
| $3.46M | ﹤0.01% |
15,295
+7,299
| +91% | +$1.65M |
|
1908
Atara Biotherapeutics
ATRA
$84.2M
| $3.45M | ﹤0.01% |
16,222
+4,519
| +39% | +$961K |
|
1909
BioXcel Therapeutics
BTAI
$50.6M
| $3.45M | ﹤0.01% |
9,634
+8,966
| +1,342% | +$3.21M |
|
1910
Enel Chile
ENIC
$5.16B
| $3.44M | ﹤0.01% |
1,035,761
-396,676
| -28% | -$1.32M |
|
1911
Chemours
CC
$2.49B
| $3.44M | ﹤0.01% |
387,434
-232,001
| -37% | -$2.06M |
|
1912
Alector
ALEC
$294M
| $3.44M | ﹤0.01% |
142,339
+26,876
| +23% | +$649K |
|
1913
Westlake Corp
WLK
$11.3B
| $3.42M | ﹤0.01% |
89,548
-330,619
| -79% | -$12.6M |
|
|
ALX
1914
Alexander's
ALX
$1.25B
| $3.41M | ﹤0.01% |
10,510
+3,804
| +57% | +$1.23M |
|
1915
Stratasys
SSYS
$835M
| $3.4M | ﹤0.01% |
212,867
+10,527
| +5% | +$168K |
|
1916
Franklin Covey
FC
$242M
| $3.39M | ﹤0.01% |
217,883
+111,412
| +105% | +$1.73M |
|
|
CNCE
1917
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
| $3.39M | ﹤0.01% |
383,035
+54,077
| +16% | +$478K |
|
1918
Ryder
R
$7.71B
| $3.38M | ﹤0.01% |
127,938
+14,351
| +13% | +$379K |
|
1919
Dorian LPG
LPG
$1.35B
| $3.38M | ﹤0.01% |
388,064
-791,477
| -67% | -$6.89M |
|
1920
Cabot Corp
CBT
$4.26B
| $3.38M | ﹤0.01% |
129,353
-78,668
| -38% | -$2.05M |
|
1921
Fluor
FLR
$6.64B
| $3.38M | ﹤0.01% |
488,726
+15,129
| +3% | +$105K |
|
1922
Restaurant Brands International
QSR
$20.7B
| $3.37M | ﹤0.01% |
84,188
-334,764
| -80% | -$13.4M |
|
|
SCU
1923
DELISTED
Sculptor Capital Management, Inc. Class A Common Stock
SCU
| $3.36M | ﹤0.01% |
248,103
-244,472
| -50% | -$3.31M |
|
1924
Nordic American Tanker
NAT
$675M
| $3.36M | ﹤0.01% |
740,840
+193,877
| +35% | +$878K |
|
1925
Matthews International
MATW
$765M
| $3.35M | ﹤0.01% |
138,545
+9,740
| +8% | +$236K |
|